Long-acting Injectable Cabotegravir/Rilpivirine Effective in a Small Patient Cohort With Virologic Failure on Oral Antiretroviral Therapy.

Brock, James B; Herrington, Peyton; Hickman, Melissa; Hickman, Aubri

Brock, James B; Herrington, Peyton; Hickman, Melissa; Hickman, Aubri.

Afiliação

Brock JB; Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center . Jackson, Mississippi, USA.
Herrington P; Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center . Jackson, Mississippi, USA.
Hickman M; Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center . Jackson, Mississippi, USA.
Hickman A; Department of Medicine, Division of Infectious Diseases, University of Mississippi Medical Center . Jackson, Mississippi, USA.

Clin Infect Dis ; 78(1): 122-124, 2024 01 25.

Article em En | MEDLINE | ID: mdl-37740255

ABSTRACT

ABSTRACT

We report 12 patients with persistent viremia on oral antiretroviral therapy who were initiated on injectable cabotegravir/rilpivirine (iCAB/RPV) without oral lead-in. All patients achieved viral suppression without any virologic rebound. iCAB/RPV may be considered as an option for patients unable to maintain suppression on oral antiretroviral therapy.

Assuntos

Fármacos Anti-HIV; Dicetopiperazinas; Infecções por HIV; Piridonas; Humanos; Rilpivirina/uso terapêutico; Fármacos Anti-HIV/uso terapêutico; Antirretrovirais/uso terapêutico; Infecções por HIV/tratamento farmacológico

Palavras-chave

HIV; therapeutics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridonas / Infecções por HIV / Fármacos Anti-HIV / Dicetopiperazinas Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google